DNA Methylation Sequencing Market

DNA methylation is an important component of epigenetics and plays an important role in maintaining normal cell function, genetic imprinting, embryonic development, and human tumorigenesis. Whole Genome Bisulfite Sequencing (WGBS), which treats genomic DNA with bisulfite to convert unmethylated cytosine C to uracil U, and performs whole-genome weighting on the treated DNA Sequencing and comparison with the reference genome to achieve single-base resolution and high-accuracy methylation level analysis from the genome level, widely used in basic mechanisms such as cell differentiation, tissue development, animal and plant breeding, human health And research fields such as disease treatment.
DNA Methylation Sequencing Market aims to provide a comprehensive presentation of the global market for DNA Methylation Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Methylation Sequencing. DNA Methylation Sequencing Market contains market size and forecasts of DNA Methylation Sequencing in global, including the following market information:
Global DNA Methylation Sequencing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global DNA Methylation Sequencing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Whole Genome Bisulfite Sequencing (WGBS) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of DNA Methylation Sequencing include Berry Genomics, Illumina Inc., Diagenode, Novogene, Qiagen N.V., Oebiotech, Biomarker, Sigma Aldrich Corporation and BGI, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the DNA Methylation Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global DNA Methylation Sequencing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global DNA Methylation Sequencing Market Segment Percentages, by Type, 2022 (%)
Whole Genome Bisulfite Sequencing (WGBS)
Reduced Representation Bisulfite Sequencing (RRBS)
MeDIP-Sequncing
Global DNA Methylation Sequencing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global DNA Methylation Sequencing Market Segment Percentages, by Application, 2022 (%)
Epigenetic Research
Massive Clinical Sample Studies
Global DNA Methylation Sequencing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global DNA Methylation Sequencing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies DNA Methylation Sequencing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies DNA Methylation Sequencing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Berry Genomics
Illumina Inc.
Diagenode
Novogene
Qiagen N.V.
Oebiotech
Biomarker
Sigma Aldrich Corporation
BGI
F. Hoffmann-La Roche Ltd.
Zymo Research Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of DNA Methylation Sequencing, market overview.
Chapter 2: Global DNA Methylation Sequencing market size in revenue.
Chapter 3: Detailed analysis of DNA Methylation Sequencing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of DNA Methylation Sequencing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.